Bicara Therapeutics is a clinical-stage company developing first-in-class biologics engineered to bring together the precision of targeted therapy and the power of immunotherapy. The company's dual-action biologics are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, potentially offering long-lasting efficacy.

Biotechnology

Bicara Therapeutics

Claire Mazumdar

David Raben

Angela Windt

Marie Bonneau

John Maraganore

Ryan Cohlhepp

Rachel Salazar

Ivan Hyep

The executive team at Bicara Therapeutics has a history of experience in a variety of industries including healthcare, finance, and pharmaceuticals. They have also held a variety of positions such as board member, business development, and corporate strategy. In addition, the team has a wealth of education between them including degrees in cancer biology, finance, and pharmacy.

CEO and Executive Team

Board of Directors

Leadership Team

CEO and Executive Team

About

Team members

Other teams at Bicara Therapeutics

Board of Directors

Leadership Team